📰 Jack Weinstein News
Page 22 - Jack Weinstein News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Weinstein. Real-time updates on events, politics, business and more.
April 27, 2022
Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering
April 27, 2022
Relief Therapeutics Holding SA / Key word(s): Patent27-Apr-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key...
April 27, 2022
Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R) 27-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR...
April 26, 2022
26.04.2022 Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing | Relief Therapeutics Holding SA | News | Nachricht | Mitteilung
April 26, 2022
Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing 26-Apr-2022 / 07:00 CET/CEST Release of an ad hoc
April 26, 2022
Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Mark...
April 22, 2022
Investegate announcements from Relief Therapeutics Holding SA, Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil
April 22, 2022
Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil 22-Apr-2022
April 22, 2022
Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil 22-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely ...
April 12, 2022
Relief Therapeutics Holding SA / Key word(s): Study results12-Apr-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss ExchangeAcer Therapeutics and Relief Therape...